Document:

exhibit
4.5

 

KINDER MORGAN, INC.

 

2021 AMENDED
AND RESTATED

 

STOCK INCENTIVE
PLAN

 

1.     PURPOSE
OF THE PLAN. The purpose of the Kinder Morgan, Inc. 2021 Amended and Restated Stock Incentive
Plan (“Plan”) is to provide incentive for future endeavors and to advance the interests of the Company and its stockholders
by encouraging ownership of the shares of Class P common stock of the Company, $0.01 par value (“Stock”), by its Employees
(as defined below) and Consultants (as defined below) and to enable the Company to compete effectively with other enterprises to attract
and retain employees and consultants as may be needed for the continued improvement of the Company’s business, through the grant
of (a) options to purchase Stock (“Options”), (b) shares of Stock that are subject to restrictions set forth in
the Plan or any individual award agreement (“Restricted Stock” or a “Restricted Stock Award”), (c) Stock
Appreciation Rights (as defined below), (d) rights to receive shares of Stock (a “Restricted Stock Unit”), (e) Performance
Compensation Awards (as defined below) and (f) Other Stock Based-Awards (as described in Section 11) (such Options, Restricted
Stock, Stock Appreciation Rights, Restricted Stock Units, Performance Compensation Awards and Other Stock-Based Awards, collectively,
the “Awards”).

 

The Plan was originally
adopted by the Board as the Kinder Morgan, Inc. 2011 Stock Incentive Plan, effective as of January 1, 2011. The Plan was amended
and restated as the Kinder Morgan, Inc. 2015 Amended and Restated Stock Incentive Plan by the Board on January 21, 2015, and
has subsequently been amended. The Plan is hereby amended and restated as of January 20, 2021, subject to approval by the Company’s
stockholders.

 

		2.	PARTICIPANTS.

 

(a)     Awards
may be granted under the Plan to any Employees and Consultants of the Company and its Affiliates (as defined below, including Affiliates
that become such after adoption of the Plan) as shall be determined by the Committee (each, a “Grantee”); provided, however,
that Incentive Stock Options may be granted only to Employees, and no Awards may be granted to any person if such grant would cause the
Plan to cease to be an “employee benefit plan” as defined in Rule 405 of Regulation C promulgated under the Securities
Act.

 

(b)     A
Consultant shall not be eligible for the grant of an Award if, at the time of grant, a Form S-8 Registration Statement under
the Securities Act (“Form S-8”) is not available to register either the offer or the sale of the Company’s
securities to such Consultant because of the nature of the services that the Consultant is providing to the Company (i.e., capital
raising), or because the Consultant is not a natural person, or as otherwise provided by the rules governing the use of
Form S-8, unless the Company determines both (i) that such grant (A) shall be registered in another manner under the
Securities Act (e.g., on a Form S-3 Registration Statement) or (B) does not require registration under the
Securities Act in order to comply with the requirements of the Securities Act, if applicable, and (ii) that such grant complies
with the securities laws of all other relevant jurisdictions.

 

3.     EFFECTIVE
DATE; TERM OF THE PLAN. The adoption of the Plan as amended and restated by the Board on January 20,
2021 is conditioned on the approval of the Company’s stockholders at the 2021 annual stockholders meeting. No Awards may be granted
under the Plan after the tenth anniversary of the Effective Date. The Plan shall remain in effect until all Awards granted under the
Plan have been satisfied or expired.

 

		4.	DEFINITIONS.

 

(a)     “Affiliate”
means an entity in which the Company has a direct or indirect ownership interest that is selected by the Committee; provided,
that, for purposes of the definition of “Change in Control,” “Affiliate” means, with respect to any Person, any
other Person that directly or indirectly controls, is controlled by or is under common control with, the Person in question. As used
in the last proviso of the preceding sentence, the term “control” means the possession, directly or indirectly, of the power
to direct or cause the direction of the management and policies of a Person, whether through ownership of voting securities, by contract
or otherwise.

 

    	 	1	 

     

    

 

(b)     “Applicable
Laws” means the requirements related to or implicated by the administration of the Plan under applicable state corporate
law, United States federal and state securities laws, the Code, any stock exchange or quotation system on which the shares of Common
Stock are listed or quoted, and the applicable laws of any foreign country or jurisdiction where Awards are granted under the Plan.

 

(c)     “Award”
means any right granted under the Plan, including an Option, a Restricted Stock Award, a Restricted Stock Unit, a Performance
Compensation Award, a Stock Appreciation Right, and Other Stock Based-Award.

 

(d)     “Award
Agreement” means a written agreement between the Company and a Grantee evidencing the terms and conditions of an individual
Award grant. Each Award Agreement shall be subject to the terms and conditions of the Plan.

 

(e)      “Benefit
Plan” means any employee benefit plan of the Company or any subsidiary of the Company, and any trust or Person organized,
appointed or established by the Company for or pursuant to the terms of any such plan, which plan, trust or Person was maintained prior
to a Change in Control.

 

(f)      “Board”
means the Board of Directors of the Company.

 

(g)     “Cause”
means, for purposes of this Plan (unless a different meaning is set forth in a written employment agreement between the Company or
one of its subsidiaries and the Grantee or in the applicable Award Agreement), following a Change of Control, a determination by the
Board (or any successor board, if applicable) that the Grantee (i) has engaged in gross negligence, gross incompetence, or
gross misconduct in the performance of the Grantee’s duties with respect to the Company, (ii) has materially breached any
material provision of any written agreement between the Company and the Grantee, (iii) has engaged in conduct that is
materially injurious to the Company, (iv) has committed an act of theft, fraud, embezzlement, misappropriation, or breach of a
fiduciary duty to the Company, or (v) has been convicted of, pleaded no contest to, any felony (or a crime of similar import in
a foreign jurisdiction); provided, however, that upon the occurrence of one or more conditions specified in (i) through
(iii) above, the Board shall provide notice to the Grantee of the existence of such condition(s) and the Grantee shall
have 30 days following receipt of such notice to correct such condition(s), the determination of whether such condition(s) has
been corrected shall be made by the Board in its sole discretion, exercised in good faith, and any failure by the Grantee to correct
such condition(s) shall result in the Grantee’s termination of employment for Cause upon expiration of such 30 day
corrective period.

 

		(h)	“Change
                                            in Control” means:

 

(i)     the
acquisition by any Person or group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange
Act, or any successor provision), including any group acting for the purpose of acquiring, holding or disposing of securities
(within the meaning of Rule 13d-5(b)(1) under the Exchange Act), other than the Permitted Holder, of beneficial ownership
(within the meaning of Rule 13d-3 under the Exchange Act, or any successor provision), of more than 20% of either the then
outstanding shares of common stock of the Company or the total voting power of the then outstanding Voting Stock of the Company;
provided that for purposes of this clause (i), the following acquisitions shall not constitute a Change in Control: (a) any
acquisition directly or indirectly by the Company; (b) any acquisition directly from the Company;
(c) any acquisition by a Benefit Plan; or (d) any reorganization, merger, consolidation, sale or similar transaction or
series of related transactions which complies with clauses (a), (b) and (c) of clause (ii) of this definition of
Change in Control;

 

(ii)    a
reorganization, merger or consolidation involving the Company, or sale of all or substantially all of the assets of the Company, or similar
transaction or series of related transactions, in each case, unless, following such reorganization, merger, consolidation, sale or transaction,
(a) 50% or more of the then outstanding shares of common stock of the corporation, or common equity securities of an entity other
than a corporation, resulting from such reorganization, merger, consolidation, sale or transaction (including an entity or ultimate parent
of an entity which as a result of such transaction owns the Company or all or substantially all of the assets of the Company) and of
the combined voting power of the then outstanding Voting Stock of such corporation or other entity are beneficially owned, directly or
indirectly, by all or substantially all of the Persons who were the beneficial owners of the outstanding common stock of the Company
immediately prior to such reorganization, merger, consolidation, sale or transaction in substantially the same proportions as their ownership,
immediately prior to such reorganization, merger, consolidation, sale or transaction, of the outstanding common stock of the Company;
(b) no Person (excluding the Permitted Holder or a Benefit Plan or any Person beneficially owning, immediately prior to such reorganization,
merger, consolidation, sale or transaction, directly or indirectly, 20% or more of the common stock of the Company then outstanding or
20% or more of the combined voting power of the Voting Stock of the Company then outstanding) beneficially owns, directly or indirectly,
20% or more of the then outstanding shares of common stock of such corporation, or common equity securities of such entity other than
a corporation, resulting from such reorganization, merger, consolidation, sale or transaction or the combined voting power of the then
outstanding Voting Stock of such corporation or other entity; and (c) at least a majority of the members of the board of directors
of the corporation, or the body which is most analogous to the board of directors of a corporation if not a corporation, resulting from
such reorganization, merger, consolidation, sale or transaction were members of the Incumbent Board (defined below) at the time of the
initial agreement or initial action by the Board providing for such reorganization, merger, consolidation, sale or transaction;

 

    	 	2	 

     

    

 

(iii)   individuals
who as of the Effective Date constitute the Board (the “Incumbent Board”) cease for any reason to constitute
at least a majority of the Board then in office; provided that the Incumbent Board (a) shall include, except as provided in clause
(b), any individual becoming a director after the Effective Date whose election by the Board or nomination for election by the Company’s
stockholders was approved by a vote of at least two-thirds (2/3) of the directors then comprising the Incumbent Board, and (b) shall
exclude any director whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to
the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other
than the Board, or any agreement intended to avoid or settle the results of any such actual or threatened solicitation; and

 

(iv)   the
approval by the stockholders of the Company of a plan of complete liquidation of the Company.

 

Notwithstanding
anything herein to the contrary, and only to the extent that an Award is subject to Code Section 409A and payment of the Award
pursuant to the application of the definition of “Change in Control” above would cause such Award not to otherwise
comply with Code Section 409A, payment of an Award may occur upon a “Change in Control” only to the extent that the
event constitutes both a “Change in Control” as defined above and a “change in control event” as defined in
Treasury Regulation Section 1.409A-3(i)(5).

 

(i)      “Change
in Control Value” means, with respect to a Change in Control, (i) the per share price offered to stockholders of the
Company in any merger, consolidation, reorganization, sale of assets or dissolution transaction, (ii) the price per share offered
to stockholders of the Company in any tender offer, exchange offer or sale or other disposition of outstanding voting stock of the Company,
or (iii) if such Change in Control occurs other than as described in clause (i) or clause (ii), the Fair Market Value per share
of the shares into which Awards are exercisable, as determined by the Committee, whichever is applicable. In the event that the consideration
offered to stockholders of the Company consists of anything other than cash, the Committee shall determine the fair cash equivalent of
the portion of the consideration offered which is other than cash.

 

(j)      “Code”
means the Internal Revenue Code of 1986, as it may be amended from time to time. Any reference to a section of the Code shall
be deemed to include a reference to any regulations and administrative guidance promulgated thereunder.

 

(k)     “Committee”
means the Board or the Compensation Committee, as administrator of the Plan.

 

(l)      “Compensation
Committee” means a committee of one or more members of the Board appointed by the Board to administer the Plan in accordance
with Section 6(c).

 

(m)    “Company”
means Kinder Morgan, Inc., a Delaware corporation.

 

    	 	3	 

     

    

 

(n)     “Consultant”
means any individual, including an advisor engaged by the Company or an Affiliate to render consulting or advisory services and
who is compensated for such services or who provides bona fide services to the Company or an Affiliate pursuant to a written agreement;
provided that such individual is a natural person and such services are not in connection with the offer or sale of securities in a capital
raising transaction and do not directly or indirectly promote or maintain a market for the Company’s securities.

 

(o)     “Date
of Grant” means the date on which the Committee adopts a resolution, or takes other appropriate action, expressly granting
an Award to a Grantee that specifies the key terms and conditions of the Award and from which the Grantee begins to benefit from or be
adversely affected by subsequent changes in the Fair Market Value of the Stock or, if a later date is set forth in such resolution, then
such date as is set forth in such resolution. In no event shall a Date of Grant be a date prior to the date of any such action by the
Committee.

 

(p)     “Director”
means a member of the Board.

 

(q)     “Effective
Date” means the date the Plan is approved by the Company’s stockholders pursuant to Section 3 hereof.

 

(r)      “Employee”
means any individual employed by the Company or an Affiliate. Notwithstanding the foregoing, for purposes of granting an Incentive
Stock Option, an individual is not an Employee unless he or she is an employee of a Parent Corporation or Subsidiary Corporation.

 

(s)      “Entity”
means a corporation, limited liability company, venture, partnership (general or limited), trust, unincorporated organization,
cooperative, association or other entity.

 

(t)      “Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

(u)     “Fair
Market Value” means, as of any date, the value of the Stock as determined below. The Fair Market Value on any date on
which the Stock is registered under Section 12 of the Exchange Act and listed on any national securities exchange shall be the
closing price of a share of Stock on any national securities exchange on such date (if such national securities exchange is not open
for trading on such date, then the closing price per share of Stock on such national securities exchange on the last day preceding
such date on which the national securities exchange was open for trading), and thereafter (i) if the Stock is admitted to
quotation on the over the counter market or any interdealer quotation system, the Fair Market Value on any given date shall not be
less than the average of the highest bid and lowest asked prices of the Stock reported for such date or, if no bid and asked prices
were reported for such date, for the last day preceding such date for which such prices were reported, or (ii) in the absence
of an established market for the Stock, the Fair Market Value determined in good faith by the Committee and such determination shall
be conclusive and binding on all persons. Notwithstanding the foregoing, the determination of fair market value in all cases shall
be in accordance with the requirements set forth under Code Section 409A and the regulations thereunder.

 

(v)     “Form S-8”
has the meaning set forth in Section 2(b).

 

(w)    “Free
Standing Rights” has the meaning set forth in Section 10(a).

 

(x)      “Good
Reason” means, for purposes of this Plan (unless a different meaning is set forth in a written employment agreement between
the Company and the Grantee or in the applicable Award Agreement), following a Change of Control, the occurrence of any of the following
conditions without the Grantee’s consent (i) a material diminution in the Grantee’s total compensation (consisting of
the sum of the Grantee’s (1) base salary and (2) incentive compensation opportunity), (ii) a material diminution
in the Grantee’s authority, duties or responsibilities, or (iii) a greater than 50 mile change in the location at which the
Grantee must perform services; provided, however, that a termination of employment for Good Reason shall not be effective unless the
Grantee provides notice to the Company or one of its subsidiaries, as applicable, of the existence of one or more of the foregoing conditions
within 80 days of the initial existence of the condition(s), such condition(s) remains uncorrected for 30 days after receipt of
such notice by the Company or one of its subsidiaries, as applicable, and the date of the Grantee’s termination of employment occurs
within 120 days after the initial existence of such condition(s).

 

    	 	4	 

     

    

 

(y)     “Grantee”
means a person to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding
Award.

 

(z)      “Incentive
Stock Option” means an Option that is designated by the Committee as an incentive stock option as described in Code Section 422
and otherwise meets the requirements set forth in the Plan.

 

(aa)   “Non-Employee
Director” means a Director who is a “non-employee director” within the meaning of Rule 16b-3.

 

(bb)   “Nonqualified
Stock Option” means an Option that is not designated by the Committee as an Incentive Stock Option.

 

(cc)   “Officer”
means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and
regulations promulgated thereunder.

 

(dd)   “Option”
means an Incentive Stock Option or a Nonqualified Stock Option granted pursuant to the Plan.

 

(ee)   “Option
Agreement” means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an
individual Option grant. Each Option Agreement shall be subject to the terms and conditions of the Plan and need not be identical.

 

(ff)     “Optionholder”
means a Grantee to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding
Option.

 

(gg)   “Parent
Corporation” means a “parent corporation” of the Company within the meaning of Code Section 424(e).

 

(hh)   “Performance
Compensation Award” means any Award designated by the Committee as a Performance Compensation Award pursuant to Section 14
of the Plan.

 

(ii)     “Performance
Criteria” means the criterion or criteria upon which the Performance Goal(s) for a Performance Period are based, which
may include any of the following, or such other criteria as determined by the Committee:

 

(i)       the
price of a share of Stock;

 

(ii)      the
basic or diluted earnings per share of Stock of the Company or earnings of a subsidiary or business unit designated by the Committee;

 

(iii)     the
total stockholder value of the Company or a subsidiary or business unit designated by the Committee;

 

(iv)    dividends
or distributions of the Company or a subsidiary or business unit designated by the Committee, in aggregate or per-share basis;

 

(v)      revenues
of the Company or a subsidiary or business unit designated by the Committee;

 

(vi)    debt
to equity, net debt, interest coverage, or net debt to adjusted or unadjusted earnings before interest, taxes, depreciation and amortization
ratios of the Company or a subsidiary or business unit designated by the Committee;

 

(vii)    other
leverage ratios of the Company or a subsidiary or business unit designated by the Committee;

 

(viii)   cash
coverage ratio of the Company or a subsidiary or business unit designated by the Committee;

 

(ix)     net
income (or income before income taxes) of the Company or a subsidiary or business unit designated by the Committee;

 

(x)      return
on investment, free cash flow, or cash flow from operating, investing or financing activities of the Company or a subsidiary or business
unit designated by the Committee;

 

    	 	5	 

     

    

 

(xi)     adjusted
or unadjusted earnings before interest, taxes, depreciation, and amortization of the Company or a subsidiary or business unit designated
by the Committee;

 

(xii)    distributable
cash flow, in aggregate or per share, of the Company or a subsidiary or business unit designated by the Committee;

 

(xiii)   capital
expenditures of the Company or a subsidiary or business unit designated by the Committee;

 

(xiv)   operations
and maintenance expense or general and administrative expense of the Company or a subsidiary or business unit designated by the Committee;

 

(xv)    return
on stockholders’ equity, return on assets or return on invested capital achieved by the Company or a subsidiary or business unit
designated by the Committee; or

 

(xvi)   environmental,
health and/or safety performance, other operating performance and/or compliance with Company policies, of the Company or a subsidiary
or business unit designated by the Committee.

 

Any one or more
of the Performance Criteria may be used on an absolute or relative basis to measure the performance of the Company and/or an Affiliate
as a whole or any division, business unit or operational unit of the Company and/or an Affiliate or any combination thereof, as the Committee
may deem appropriate, or any of the above Performance Criteria as compared to the performance of a group of comparable companies, or
published or special index that the Committee, in its sole discretion, deems appropriate, or the Committee may select Performance Criterion
(i) above as compared to various stock market indices. The Committee also has the authority to provide for accelerated vesting of
any Award based on the achievement of Performance Goals pursuant to the Performance Criteria specified in this paragraph. To the extent
that applicable tax and/or securities laws permit Committee discretion to alter the governing Performance Criteria without obtaining
stockholder approval of such changes, the Committee shall have sole discretion to make such changes without obtaining stockholder approval.

 

(jj)     “Performance
Formula” means, for a Performance Period, one or more objective formulas that the Committee may establish to be applied
against the relevant Performance Goal to determine, with regard to the Performance Compensation Award of a particular Grantee, whether
all, some portion but less than all, or none of the Performance Compensation Award has been earned for the Performance Period.

 

(kk)   “Performance
Goals” means, for a Performance Period, one or more goals established by the Committee for the Performance Period based
upon the Performance Criteria determined by the Committee in its discretion. The Committee is authorized, in its sole and absolute discretion,
to adjust or modify the calculation of a Performance Goal for a Performance Period in connection with any one or more of the following
events or such other events as determined by the Committee:

 

(i)       asset
write-downs;

 

(ii)      litigation
or claim judgments or settlements;

 

(iii)     the
effect of changes in tax laws, accounting principles, or other laws or regulatory rules affecting reported results;

 

(iv)     any
reorganization and restructuring programs;

 

(v)      unusual
or infrequently occurring items as described in Income Statement — Unusual or Infrequently Occurring Items (Subtopic 225-30) (or
any successor or pronouncement thereto) and/or in management’s discussion and analysis of financial condition and results of operations
appearing in the Company’s annual report to stockholders for the applicable year;

 

(vi)     acquisitions
or divestitures;

 

(vii)    any
other specific unusual or infrequently occurring events, or objectively determinable category thereof;

 

    	 	6	 

     

    

 

(viii)   foreign
exchange gains and losses; and

 

(ix)     a
change in the Company’s fiscal year.

 

(ll)     “Performance
Period” means one or more periods of time as the Committee may select, over which the attainment of one or more Performance
Goals will be measured for the purpose of determining a Grantee’s right to and the payment of a Performance Compensation Award.

 

(mm) “Permitted
Holder” means Richard D. Kinder.

 

(nn)  “Person” means a natural person or an entity.

 

(oo)  “Plan”
means this Kinder Morgan, Inc. 2021 Amended and Restated Stock Incentive Plan.

 

(pp)  “Related Stock Appreciation
Rights” has the meaning set forth in Section 10(a).

 

(qq)  “Restricted
Period” means the period established by the Committee with respect to an Award during which the Award remains subject to
forfeiture and is either not exercisable by or payable to the Grantee, as the case may be.

 

(rr)    “Restricted
Stock” means any Award granted pursuant to Section 8(a).

 

(ss)   “Restricted
Stock Unit” means any Award granted pursuant to Section 9(a).

 

(tt)    “Rule 16b-3”
means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.

 

(uu)  “SAR Amount”
has the meaning set forth in Section 10(k).

 

(vv)  “SAR
exercise price” has the meaning set forth in Section 10(a).

 

(ww) “Securities Act” means
the Securities Act of 1933, as amended.

 

(xx)   “Share
for Share Exchange” has the meaning set forth in Section 7(f).

 

(yy)  “Stock”
means shares of Class P common stock of the Company, $0.01 par value.

 

(zz)   “Stock Appreciation Right”
means any Award granted pursuant to Section 10.

 

(aaa)  “Subsidiary
Corporation” means a “subsidiary corporation” of the Company within the meaning of Code Section 424(f).

 

(bbb) “Substitute
Award” has the meaning set forth in Section 5(c).

 

(ccc)  “Total Share Reserve” has the meaning
set forth in Section 5(a).

 

(ddd)  “Voting
Stock” means, (i) with respect to a corporation, all securities of such corporation of any class or series that are
entitled to vote generally in the election of, or to appoint by contract, directors of such corporation (excluding any class or series
that would be entitled so to vote by reason of the occurrence of any contingency, so long as such contingency has not occurred) and (ii) with
respect to an entity which is not a corporation, all securities of any class or series that are entitled to vote generally in the election
of, or to appoint by contract, members of the body which is most analogous to the board of directors of a corporation.

 

		5.	STOCK
                                            SUBJECT TO THE PLAN.

 

(a)     Subject
to adjustment in accordance with the provisions of Section 12, the aggregate number of shares of Stock for which Awards may be
granted under the Plan shall not exceed 63,000,000 (inclusive of shares granted with respect to Awards under the Plan prior to the
Effective Date), any or all of which may be issued pursuant to Incentive Stock Options (the “Total Share Reserve”);
provided, that any shares of Stock subject to an Award that expires or is canceled, forfeited, or terminated without issuance of the
full number of shares of Stock to which the Award related will again be available for issuance under the Plan. The exercise of a
Stock Appreciation Right for cash or the payment of any Award in cash shall not count against the Total Share Reserve.
Notwithstanding anything to the contrary contained herein: (i) shares of Stock surrendered or withheld in payment of the
exercise price of an Option shall count against the Total Share Reserve and shall not again be made available for the grant of
Awards under the Plan; and (ii) shares of Stock withheld by the Company to satisfy any tax withholding obligation shall count
against the Total Share Reserve and shall not again be made available for the grant of Awards under the Plan. No fractional shares
of Stock may be issued hereunder.

 

    	 	7	 

     

    

 

(b)     The
Stock to be delivered pursuant to an Award shall be made available, at the discretion of the Committee, either from authorized but previously
unissued shares of Stock or from Stock reacquired by the Company, including Stock purchased in the open market, and Stock held in the
treasury of the Company.

 

(c)     Awards
may, in the sole discretion of the Committee, be granted under the Plan in assumption of, or in substitution for, outstanding awards
previously granted by an entity acquired by the Company or with which the Company combines (“Substitute Awards”). Substitute
Awards shall not be counted against the Total Share Reserve; provided, that, Substitute Awards issued in connection with the assumption
of, or in substitution for, outstanding options intended to qualify as Incentive Stock Options shall be counted against the number of
shares of Stock that may be issued pursuant to Incentive Stock Options. Subject to applicable stock exchange requirements, available
shares under a shareholder-approved plan of an entity directly or indirectly acquired by the Company or with which the Company combines
(as appropriately adjusted to reflect such acquisition or transaction) may be used for Awards under the Plan and shares so used shall
not count against the Total Share Reserve.

 

(d)     Notwithstanding
the minimum periods specified in Sections 7(d), 8(f), 9(f), 10(c), 10(d) and 11 for Awards to be exercisable or vest, (i) up
to ten percent (10%) of the shares of Stock available for Awards under the Plan as of the Effective Date, subject to adjustment under
Section 12, may be granted pursuant to Awards with a minimum exercisability or vesting requirement of twelve months, provided that
any Award that provides for vesting of a portion thereof during the 36-month period following the grant and for vesting of the remainder
thereof after 36 months shall count against such ten percent (10%) only with respect to such portion of the Award that vests during the
36-month period following the grant; (ii) in the event of a Change in Control, Section 12(e) shall apply; and (iii) each
Award Agreement may provide for accelerated exercisability or vesting in the event of a Grantee’s death, disability, termination
by the Company other than for Cause, termination by the Grantee for Good Reason, or retirement.

 

		6.	ADMINISTRATION
                                            OF THE PLAN.

 

(a)     The
Plan shall be administered by the Board unless and until the Board delegates administration to a Compensation Committee, as provided
in Section 6(c).

 

(b)     The
Board shall have the power and authority: (i) to construe and interpret the Plan and apply its provisions; (ii) to
promulgate, amend, and rescind rules and regulations relating to the administration of the Plan; (iii) to authorize any
person to execute, on behalf of the Company, any instrument required to carry out the purposes of the Plan; (iv) to delegate
its authority to one or more Officers of the Company with respect to awards that do not involve “insiders” within the
meaning of Section 16 of the Exchange Act; (v) to determine when Awards are to be granted under the Plan and the
applicable Date of Grant; (vi) from time to time to select, subject to the limitations set forth in this Plan, those Grantees
to whom Awards shall be granted and to make any such grants; (vii) to determine the number of shares of Stock to be made
subject to each Award; (viii) to prescribe the terms and conditions of each Award, including, without limitation, the exercise
price and medium of payment, vesting and forfeiture provisions and right of repurchase provisions, and to specify the provisions of
the Award Agreement relating to such grant or sale; (ix) to designate an Award as a Performance Compensation Award and to
select the Performance Criteria that will be used to establish the Performance Goals; (x) to amend any outstanding Awards,
including for the purpose of modifying the time or manner of vesting, or the term of any outstanding Award; (xi) to determine
the duration and purpose of leaves of absences which may be granted to a Grantee without constituting termination of his or her
employment for purposes of the Plan, which periods shall be no shorter than the periods generally applicable to Employees under the
Company’s employment policies; (xii) to make decisions with respect to outstanding Awards that may become necessary upon
a Change in Control or an event described in Section 12; (xiii) to interpret, administer, reconcile any inconsistency in,
correct any defect in and/or supply any omission in the Plan and any instrument or agreement relating to, or Award granted under,
the Plan; and (xiv) to exercise discretion to make any and all other determinations which it determines to be necessary or
advisable for administration of the Plan. Except as provided in Sections 7(b) or 12, the terms of outstanding Awards may not be
amended to reduce the exercise price of outstanding Options or Stock Appreciation Rights or to cancel outstanding Options or Stock
Appreciation Rights in exchange for cash, other Options, Stock Appreciation Rights or other Awards with an exercise price that is
less than the exercise price of the original Options or Stock Appreciation Rights without stockholder approval.

 

    	 	8	 

     

    

 

		(c)	The Compensation Committee.

 

(i)       The
Board may delegate administration of the Plan to a Compensation Committee of one or more members of the Board. If administration is delegated
to a Compensation Committee, the Compensation Committee shall have, in connection with the administration of the Plan, the powers theretofore
possessed by the Board as described in Section 6(b), including the power to delegate to a subcommittee any of the administrative
powers the Compensation Committee is authorized to exercise, subject, however, to such resolutions, not inconsistent with the provisions
of the Plan, as may be adopted from time to time by the Board. The Board may rescind any delegation to the Compensation Committee at
any time and revest in the Board the administration of the Plan.

 

(ii)      The
Board shall have discretion to determine whether or not it intends to comply with the exemption requirements of Rule 16b-3, if applicable.
If the Board intends to satisfy such exemption requirements, with respect to Awards to any insider subject to Section 16 of the
Exchange Act, the Compensation Committee shall be a compensation committee of the Board that at all times consists solely of two or more
Non-Employee Directors. Within the scope of such authority, the Board or the Compensation Committee may delegate to a committee of one
or more members of the Board who are not Non-Employee Directors the authority to grant Awards to eligible persons who are not then subject
to Section 16 of the Exchange Act. Nothing herein shall create an inference that an Award is not validly granted under the Plan
in the event Awards are granted under the Plan by a compensation committee of the Board that does not at all times consist solely of
two or more Non-Employee Directors.

 

(d)     The
interpretation and construction of any provision of the Plan or of any Award granted under it by the Committee shall be final, conclusive
and binding upon all parties, including the Company, its stockholders and Directors, and the executives and employees of the Company
and its Affiliates. No member of the Committee shall be liable to the Company, any stockholder, any Grantee or any employee of the Company
or its Affiliates for any action or determination made in good faith with respect to the Plan or any Award granted under it. No member
of the Committee may vote on any Award to be granted to him or her.

 

(e)     In
addition to such other rights of indemnification as they may have as Directors or members of the Committee, and to the extent
allowed by Applicable Laws, the Committee shall be indemnified by the Company against the reasonable expenses, including reasonable
attorney’s fees, actually incurred in connection with any action, suit or proceeding or in connection with any appeal therein,
to which the Committee may be party by reason of any action taken or failure to act under or in connection with the Plan or any
Award granted under the Plan, and against all amounts paid by the Committee in settlement thereof (provided that the settlement has
been approved by the Company, which approval shall not be unreasonably withheld) or paid by the Committee in satisfaction of a
judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit
or proceeding that such Committee did not act in good faith and in a manner which such person reasonably believed to be in the best
interests of the Company, or in the case of a criminal proceeding, had no reason to believe that the conduct complained of was
unlawful; provided, however, that within 60 days after the institution of any such action, suit or proceeding, such Committee shall,
in writing, offer the Company the opportunity at its own expense to handle and defend such action, suit or proceeding.

 

(f)      The
expenses of administering the Plan shall be borne by the Company.

 

    	 	9	 

     

    

 

		7.	OPTIONS.

 

(a)     An
Option granted under the Plan may be either an Incentive Stock Option or a Nonqualified Stock Option; provided, however, that no Incentive
Stock Option shall be granted to any individual who is not an employee of the Company, a Parent Corporation or Subsidiary Corporation.
Each Option shall be in such form and shall contain such terms and conditions as the Committee shall deem appropriate. Notwithstanding
anything herein to the contrary, it is the intention of the Company that all Options granted hereunder shall comply with the provisions
and requirements of Code Section 409A to the extent applicable. The provisions of separate Options need not be identical. Notwithstanding
the foregoing, the Company shall have no liability to any Optionholder or any other person if an Option designated as an Incentive Stock
Option fails to qualify as such at any time or if an Option is determined to constitute “nonqualified deferred compensation”
within the meaning of Code Section 409A and the terms of such Option do not satisfy the requirements of Code Section 409A.

 

(b)     The
exercise price per share of each Option shall be not less than 100% of the Fair Market Value of a share of Stock on the date the Option
is granted. Notwithstanding the foregoing, an Option may be granted with an exercise price lower than that set forth in the preceding
sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions
of Code Section 424(a) or 409A. No Option shall include any feature for the deferral of compensation other than the deferral
of recognition of income until the exercise of the Option.

 

(c)     The
expiration date of an Option granted under the Plan shall be as determined by the Committee at the time of grant, provided that each
such Option shall expire not more than ten years after the date the Option is granted.

 

(d)     Each
Option shall become exercisable in whole or in part or in installments at such time or times as the Committee may prescribe at the time
the Option is granted and specify in the Option Agreement; provided, that no Option shall be exercisable less than 36 months after it
is granted, except in the event of a Change in Control as provided in Section 12(e) or as provided in Section 5(d).

 

(e)     The
exercise price of an Option shall be paid, to the extent permitted by applicable statutes and regulations, either (i) in cash
or by certified or bank check, or (ii) in the discretion of the Committee, upon such terms as the Committee shall approve:
(A) by delivery to the Company of other shares of Stock, duly endorsed for transfer to the Company, with a Fair Market Value on
the date of delivery equal to the exercise price (or portion thereof) due for the number of shares of Stock being acquired, or by
means of attestation whereby the Optionholder identifies for delivery specific shares of Stock that have a Fair Market Value on the
date of attestation equal to the exercise price (or portion thereof) and receives a number of shares of Stock equal to the
difference between the number of shares of Stock thereby purchased and the number of identified attestation shares of Stock (a
 “Share for Share Exchange”); (B) by a “cashless” exercise program established with a broker;
(C) by reduction in the number of shares of Stock otherwise deliverable upon exercise of such Option with a Fair Market Value
equal to the aggregate exercise price at the time of exercise; or (D) in any other form of legal consideration that may be
acceptable to the Committee. Unless otherwise specifically provided in the Option Agreement, the exercise price of Stock acquired
pursuant to an Option that is paid by delivery (or attestation) to the Company of other Stock acquired, directly or indirectly from
the Company, shall be paid only by shares of the Stock that have been held for more than six months (or such longer or shorter
period of time, if any, required to avoid a charge to earnings for financial accounting purposes). Notwithstanding the foregoing,
during any period for which the Stock is publicly traded (i.e., the Stock is listed on any established stock exchange or a national
market system) an exercise by an executive officer that involves or may involve a direct or indirect extension of credit or
arrangement of an extension of credit by the Company, directly or indirectly, in violation of Section 402(a) of the
Sarbanes- Oxley Act (codified as Section 13(k) of the Exchange Act) shall be prohibited with respect to any Award under
this Plan.

 

(f)      A
Nonqualified Stock Option may, in the sole discretion of the Committee, be transferable to a permitted transferee upon written
approval by the Committee to the extent provided in the Option Agreement. A permitted transferee includes: (i) a transfer by
gift or domestic relations order to a member of the Optionholder’s immediate family (child, stepchild, grandchild, parent,
stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law, or sister-in-law, including adoptive relationships), any person sharing the Optionholder’s household (other
than a tenant or employee), a trust in which these persons have more than 50% of the beneficial interest, a foundation in which
these persons (or the Optionholder) control the management of assets, and any other entity in which these persons (or the
Optionholder) own more than 50% of the voting interests; (ii) third parties designated by the Committee in connection with a
program established and approved by the Committee pursuant to which Optionholders may receive a cash payment or other consideration
in consideration for the transfer of such Option; and (iii) such other transferees as may be permitted by the Committee in its
sole discretion. If the Option does not provide for transferability, then the Option shall not be transferable except by will or by
the laws of descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder.
Notwithstanding the foregoing, the Optionholder may, by delivering written notice to the Company, in a form satisfactory to the
Company, designate a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the
Option.

 

    	 	10	 

     

    

 

(g)     No
Optionholder shall have any rights to distributions or other rights of a common stockholder with respect to Stock subject to an Option
prior to the purchase of such Stock upon exercise of the Option.

 

(h)     Each
individual Option Agreement shall describe the effect of the Optionholder’s termination of employment or service with the Company
or an Affiliate on the exercisability of the Options held by the Optionholder, provided that no Option shall remain exercisable beyond
the expiration of the original term of the Option. Notwithstanding the foregoing, the Committee may, at any time prior to any termination
of such employment or service, determine in its sole discretion that the exercise of any Option after termination of such employment
or other relationship with the Company shall be subject to satisfaction of the conditions precedent that the Optionholder refrain from
engaging, directly or indirectly, in any activity which is competitive with any activity of the Company or any of its Affiliates thereof
and from otherwise acting, either prior to or after termination of such employment or other relationship, in any manner inimical or in
any way contrary to the best interests of the Company and that the Optionholder furnish to the Company such information with respect
to the satisfaction of the foregoing condition precedent as the Committee shall reasonably request.

 

(i)      An
Optionholder’s beneficiary designated pursuant to Section 17(h), or if no such designation of any beneficiary has been made,
the legal representative of such Optionholder or such other person entitled thereto as determined by a court of competent jurisdiction,
may exercise, in accordance with and subject to the provisions of this Section 7, any unterminated and unexpired Option granted
to such Optionholder to the same extent that the Optionholder himself or herself could have exercised such Option were he alive or able;
provided, however, that no Option granted under the Plan shall be exercisable for more shares of Stock than the Optionholder could have
purchased thereunder on the date his or her employment by, or other relationship with, the Company and its Affiliates was terminated.

 

(j)      Notwithstanding
anything to the contrary in this Section 7, Incentive Stock Options shall be subject to the following requirements:

 

(i)       If
an Incentive Stock Option is granted to an Optionholder who owns stock representing more than ten percent of the voting power of all
classes of stock of the Company or of a Parent Corporation or Subsidiary Corporation, the Option shall expire not more than five years
after the date the Option is granted and the exercise price shall be not less than 110% of the Fair Market Value of a share of Stock
on the date the Option is granted.

 

(ii)      An
Incentive Stock Option shall not be transferable except by will or by the laws of descent and distribution and shall be exercisable during
the lifetime of the Optionholder only by the Optionholder.

 

(iii)     To
the extent the aggregate Fair Market Value (determined as of the Date of Grant) of Stock for which Incentive Stock Options are exercisable
for the first time by any Optionholder during any calendar year (under all plans of the Company, a Parent Corporation or a Subsidiary
Corporation) exceeds $100,000, such Incentive Stock Options shall be treated as Nonqualified Stock Options.

 

(iv)    Any
Grantee who shall make a “disposition” (as defined in Code Section 424) of all or any portion of shares of Stock acquired
upon exercise of an Incentive Stock Option within two years from the Date of Grant of such Incentive Stock Option or within one year
after the issuance of the shares of Stock acquired upon exercise of such Incentive Stock Option shall be required to immediately advise
the Company in writing as to the occurrence of the sale and the price realized upon the sale of such shares of Stock.

 

    	 	11	 

     

    

 

(k)     Notwithstanding
anything to the contrary in this Section 7, if an Option is granted to an Employee with respect to whom Stock does not constitute
 “service recipient stock” (as defined in Treasury Regulation Section 1.409A-1(b)(5)(iii)), the Option shall comply with
Code Section 409A to the extent applicable.

 

		8.	RESTRICTED
                                            STOCK.

 

(a)     Restricted
Stock is an Award of actual shares of Stock which may, but need not, provide that, for the applicable Restricted Period, such Restricted
Stock will be subject to forfeiture and may not be sold, assigned, transferred or otherwise disposed of, pledged or hypothecated as collateral
for a loan or as security for the performance of any obligation or for any other purpose. In the discretion of the Committee, an award
of Restricted Stock may be granted as a Performance Compensation Award under Section 14. Each grant of Restricted Stock under the
Plan shall be evidenced by an Award Agreement and shall be subject to the conditions set forth in this Section 8, and to such other
conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement.

 

(b)     Each
Grantee granted Restricted Stock shall execute and deliver to the Company an Award Agreement with respect to the Restricted Stock
setting forth the restrictions and other terms and conditions applicable to such Restricted Stock. The Committee may denote the
Restricted Stock as restricted, if issued in book-entry or electronic form. If the Committee determines that the Restricted Stock
shall be held by the Company or in escrow rather than issued in book-entry or electronic form or delivered to the Grantee pending
the release of the applicable restrictions, the Committee may require the Grantee to additionally execute and deliver to the Company
(i) an escrow agreement satisfactory to the Committee, if applicable, (ii) the appropriate blank stock power with respect
to the Restricted Stock covered by such agreement, and (iii) such other documents as the Company determines are necessary or
advisable to effectuate such actions. If a Grantee shall fail to execute an agreement evidencing an Award of Restricted Stock and,
if applicable, an escrow agreement, stock power and other applicable documents, the Award shall be null and void. Subject to the
restrictions set forth in the Award Agreement, the Grantee generally shall have the rights and privileges of a Class P common
stockholder as to such Restricted Stock, including the right to vote such Restricted Stock and the right to receive dividends. At
the discretion of the Committee, cash dividends and Stock dividends with respect to the Restricted Stock may be either currently
paid to the Grantee or withheld by the Company for the Grantee’s account, and interest may be credited on the amount of the
cash dividends withheld at a rate and subject to such terms as determined by the Committee. The cash dividends or Stock dividends so
withheld by the Committee and attributable to any particular share of Restricted Stock (and earnings thereon, if applicable) shall
be distributed to the Grantee in cash or, at the discretion of the Committee, in Stock having a Fair Market Value equal to the
amount of such dividends, if applicable, upon the release of restrictions on such Restricted Stock or, if such Restricted Stock is
forfeited, such dividends (and earnings thereon, if applicable) shall also be forfeited.

 

(c)     Restricted
Stock awarded to a Grantee shall be subject to the following restrictions until the expiration of the Restricted Period, and to such
other terms and conditions as may be set forth in the applicable Award Agreement: (A) if an escrow arrangement is used, the Grantee
shall not be entitled to delivery of the Stock certificate; (B) the Stock shall be subject to the restrictions on transferability
set forth in the Award Agreement; (C) the Stock shall be subject to forfeiture to the extent provided in the applicable Award Agreement;
and (D) to the extent such shares of Stock are forfeited, the Stock certificates (if applicable) shall be returned to the Company,
and all rights of the Grantee to such shares of Stock and as a stockholder with respect to such shares of Stock shall terminate without
further obligation on the part of the Company.

 

(d)     The
Committee shall have the authority to remove any or all of the restrictions on Restricted Stock whenever it may determine that, by reason
of changes in Applicable Laws or other changes in circumstances arising after the date the Restricted Stock is granted, such action is
appropriate.

 

(e)     Upon
termination of employment with or service to the Company or any of its Affiliates (including by reason of such Affiliate ceasing to be
an Affiliate of the Company), during the applicable Restricted Period, Restricted Stock shall be forfeited; provided, however, that the
Committee may provide, by rule or regulation or in any Award Agreement, for accelerated vesting of Restricted Stock in the event
of a Grantee’s death, disability, termination by the Company other than for Cause, termination by the Grantee for Good Reason,
or retirement.

 

    	 	12	 

     

    

 

(f)      With
respect to Restricted Stock, the Restricted Period shall commence on the Date of Grant and end at the time or times set forth on a schedule
established by the Committee in the applicable Award Agreement; provided, that no Restricted Period shall be less than 36 months, except
in the event of a Change in Control as provided in Section 12(e) or as provided in Section 5(d).

 

(g)     Upon
the expiration of the Restricted Period with respect to any Restricted Stock, the restrictions set forth in this Section 8 and the
applicable Award Agreement shall be of no further force or effect with respect to such Stock, except as set forth in the applicable Award
Agreement. The Grantee shall be entitled to have the legend required by Section 8(h) removed from his Stock certificate or
similar notation removed from such shares if issued in book-entry or electronic form. If an escrow arrangement is used, upon such expiration,
the Company shall deliver to the Grantee, or his beneficiary, without charge, the Stock certificate evidencing the Restricted Stock with
respect to which the Restricted Period has expired (to the nearest full share of Stock) and any cash distributions or Stock dividends
credited to the Grantee’s account with respect to such Restricted Stock and the interest thereon, if any.

 

(h)     Each
certificate representing Restricted Stock awarded under the Plan shall bear a legend in the form the Company deems appropriate, and any
Award of Restricted Stock issued in book-entry or electronic form shall be subject to such legend.

 

		9.	RESTRICTED
                                            STOCK UNITS.

 

(a)     A
Restricted Stock Unit is an Award entitling the Grantee to receive a share of Stock or cash equal to the Fair Market Value of a share
of Stock to be delivered at the time such Award vests. In the discretion of the Committee, an Award of Restricted Stock Units may be
granted as a Performance Compensation Award under Section 14. Each Award of Restricted Stock Units shall be evidenced by an Award
Agreement and shall be subject to the conditions set forth in this Section 9(a), and to such other conditions not inconsistent with
the Plan as may be reflected in the applicable Award Agreement.

 

(b)     The
terms and conditions of a grant of Restricted Stock Units shall be reflected in a written Award Agreement. No Stock shall be issued at
the time a Restricted Stock Unit is granted, and the Company will not be required to set aside a fund for the payment of any such Award.
A Grantee shall have no voting rights with respect to any Restricted Stock Units granted hereunder. At the discretion of the Committee,
each Restricted Stock Unit (representing one share of Stock) may be credited with an amount equal to the cash distributions and Stock
dividends paid by the Company in respect of one share of Stock (“Dividend Equivalents”). At the discretion of the Committee,
Dividend Equivalents may be either paid to the Grantee as dividends are paid to stockholders of the Company or withheld by the Company
for the Grantee’s account, and interest may be credited on the amount of cash Dividend Equivalents withheld at a rate and subject
to such terms as determined by the Committee. Dividend Equivalents credited to a Grantee’s account and attributable to any particular
Restricted Stock Unit (and earnings thereon, if applicable) shall be distributed in cash or, at the discretion of the Committee, in Stock
having a Fair Market Value equal to the amount of such Dividend Equivalents and earnings, if applicable, to the Grantee upon settlement
of such Restricted Stock Unit or, if such Restricted Stock Unit is forfeited, such Dividend Equivalents (and earnings thereon, if applicable)
shall also be forfeited.

 

(c)     Restricted
Stock Units awarded to any Grantee shall be subject to (A) forfeiture until the expiration of the Restricted Period, and satisfaction
of any applicable Performance Goals during such period, to the extent provided in the applicable Award Agreement, and to the extent such
Restricted Stock Units are forfeited, all rights of the Grantee to such Restricted Stock Units shall terminate without further obligation
on the part of the Company and (B) such other terms and conditions as may be set forth in the applicable Award Agreement.

 

(d)     The
Committee shall have the authority to remove any or all of the forfeiture conditions on the Restricted Stock Units whenever it may determine
that, by reason of changes in Applicable Laws or other changes in circumstances arising after the date the Restricted Stock Units are
granted, such action is appropriate.

 

    	 	13	 

     

    

 

(e)     Upon
termination of employment with or service to the Company or any of its Affiliates (including by reason of such Affiliate ceasing to
be an Affiliate of the Company), during the applicable Restricted Period, Restricted Stock Units shall be forfeited; provided,
however, that the Committee may provide, by rule or regulation or in any Award Agreement, for accelerated vesting of Restricted
Stock Units in the event of a Grantee’s death, disability, termination by the Company other than for Cause, termination by the
Grantee for Good Reason, or retirement.

 

(f)      With
respect to Restricted Stock Units, the Restricted Period shall commence on the Date of Grant and end at the time or times set forth on
a schedule established by the Committee in the applicable Award Agreement; provided, that no Restricted Period shall be less than 36
months, except in the event of a Change in Control as provided in Section 12(e) or as provided in Section 5(d).

 

(g)     Upon
the expiration of the Restricted Period with respect to any outstanding Restricted Stock Units, the Company shall deliver to the
Grantee, or his beneficiary, without charge, one share of Stock for each such outstanding Restricted Stock Unit (“Vested
Unit”) and cash equal to any Dividend Equivalents credited with respect to each such Vested Unit in accordance with
Section 9(b) hereof and the interest thereon or, at the discretion of the Committee, in Stock having a Fair Market Value
equal to such Dividend Equivalents’ interest thereon, if any; provided, however, that, if explicitly provided in the
applicable Award Agreement, the Committee may, in its sole discretion, elect to pay cash or part cash and part Stock in lieu of
delivering only Stock for Vested Units. If a cash payment is made in lieu of delivering Stock, the amount of such payment shall be
equal to the Fair Market Value of the Stock as of the date on which the Restricted Period lapsed with respect to such Vested
Unit.

 

		10.	STOCK
                                            APPRECIATION RIGHTS.

 

(a)     A
Stock Appreciation Right means the right pursuant to an Award granted under this Section 10 to receive an amount set forth in
paragraph (e) below upon the exercise of the Award. Stock Appreciation Rights may be granted either alone (“Free Standing
Rights”) or in conjunction with all or part of any Option granted under the Plan (“Related Stock Appreciation
Rights”). The Committee shall determine the Grantee to whom, and the time or times at which, grants of Stock Appreciation
Rights shall be made; the number of shares of Stock to be subject to the Stock Appreciation Right; the exercise price per share of
Stock (“SAR exercise price”); and all other conditions of Stock Appreciation Rights. No Related Stock Appreciation Right
may be granted for more shares of Stock than are subject to the Option to which it relates. A Stock Appreciation Right must be
granted with an SAR exercise price not less than the Fair Market Value of a share of Stock on the Date of Grant. The number of
shares of Stock subject to the Stock Appreciation Right must be fixed on the Date of Grant of the Stock Appreciation Right, and the
right must not include any feature for the deferral of compensation other than the deferral of recognition of income until the
exercise of the right. The provisions of Stock Appreciation Rights need not be the same with respect to each Grantee. Stock
Appreciation Rights granted under the Plan shall be subject to the following terms and conditions set forth in this Section 10
and shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem
desirable, as set forth in the applicable Award Agreement. The term of a Stock Appreciation Right granted under the Plan shall be
determined by the Committee; provided, however, no Stock Appreciation Right shall be exercisable later than the tenth anniversary of
the Date of Grant.

 

(b)     The
Grantee of a Stock Appreciation Right shall not have any rights with respect to such Award, unless and until such recipient has executed
an Award Agreement and delivered a fully executed copy thereof to the Company. Grantees who are granted Stock Appreciation Rights shall
have no rights as common stockholders of the Company with respect to the grant or exercise of such rights.

 

(c)     Free
Standing Rights shall be exercisable at such time or times and subject to such terms and conditions as shall be determined by the Committee
at or after grant; provided, that no Free Standing Right shall be exercisable less than 36 months after it is granted, except in the
event of a Change in Control as provided in Section 12(e) or as provided in Section 5(d).

 

(d)     Related
Stock Appreciation Rights shall be exercisable only at such time or times and to the extent that the Options to which they relate shall
be exercisable in accordance with the provisions of Section 7 above and this Section 10 of the Plan; provided, that no Related
Stock Appreciation Right shall be exercisable less than 36 months after it is granted, except in the event of a Change in Control as
provided in Section 12(e) or as provided in Section 5(d).

 

    	 	14	 

     

    

 

(e)     Upon
exercise of a Stock Appreciation Right, the Grantee shall be entitled to receive from the Company an amount equal to the product of
(i) the excess of the Fair Market Value, on the date of exercise, of one share of Stock over the SAR exercise price per share
of Stock specified in such Stock Appreciation Right or its related Option, multiplied by (ii) the number of shares of Stock for
which such Stock Appreciation Right is exercised. Payment with respect to the exercise of a Stock Appreciation Right that is not
subject to Code Section 409A shall be paid on the date of exercise. Payment with respect to the exercise of a Stock
Appreciation Right that is subject to Code Section 409A shall be paid at the time specified in the Award Agreement in
accordance with the provisions of Section 10(k). Payment may be made in the form of Stock (with or without restrictions as to
substantial risk of forfeiture and transferability, as determined by the Committee in its sole discretion), cash or a combination
thereof, as determined by the Committee. Fractional shares of Stock resulting from the exercise of a Stock Appreciation Right
pursuant to this Section 10 shall be settled in cash.

 

(f)      The
SAR exercise price of a Free Standing Right shall be determined by the Committee, but shall not be less than 100% of the Fair Market
Value of one share of Stock on the Date of Grant of such Stock Appreciation Right. A Related Stock Appreciation Right granted simultaneously
with or subsequent to the grant of an Option and in conjunction therewith or in the alternative thereto shall have the same exercise
price as the related Option, shall be transferable only upon the same terms and conditions as the related Option, and shall be exercisable
only to the same extent as the related Option; provided, however, that a Stock Appreciation Right, by its terms, shall be exercisable
only when the Fair Market Value per share of Stock subject to the Stock Appreciation Right and related Option exceeds the SAR exercise
price per share of Stock thereof and no Stock Appreciation Rights may be granted in tandem with an Option unless the Committee determines
that the requirements of Section 10(a) are satisfied.

 

(g)     Upon
any exercise of a Related Stock Appreciation Right, the number of shares of Stock for which the related Option shall be exercisable shall
be reduced by the number of shares of Stock for which the Stock Appreciation Right shall have been exercised. The number of shares of
Stock for which a Related Stock Appreciation Right shall be exercisable shall be reduced upon any exercise of the related Option by the
number of shares of Stock for which such Option shall have been exercised.

 

(h)     Stock
Appreciation Rights shall be transferable only when and to the extent that an Option would be transferable under Section 7 of the
Plan.

 

(i)      Each
individual Award Agreement shall describe the effect of the Grantee’s termination of employment or service with the Company or
an Affiliate on the exercisability of the Stock Appreciation Rights held by the Grantee, provided that no Stock Appreciation Right shall
remain exercisable beyond the expiration of the original term of the Stock Appreciation Right. Notwithstanding the foregoing, the Committee
may, at any time prior to any termination of such employment or service, determine in its sole discretion that the exercise of any Stock
Appreciation Right after termination of such employment or other relationship with the Company shall be subject to satisfaction of the
conditions precedent that the Grantee refrain from engaging, directly or indirectly, in any activity which is competitive with any activity
of the Company or any of its Affiliates thereof and from otherwise acting, either prior to or after termination of such employment or
other relationship, in any manner inimical or in any way contrary to the best interests of the Company and that the Grantee furnish to
the Company such information with respect to the satisfaction of the foregoing condition precedent as the Committee shall reasonably
request.

 

(j)      A
Stock Appreciation Right that is subject to Code Section 409A shall satisfy the requirements of this Section 10(j) and
the additional conditions applicable to nonqualified deferred compensation under Code Section 409A. The requirements herein shall
apply in the event any Stock Appreciation Right under this Plan is granted with an SAR exercise price less than the Fair Market Value
of the Stock underlying the Award on the date the Stock Appreciation Right is granted (regardless of whether or not such SAR exercise
price is intentionally or unintentionally priced at less than Fair Market Value, or is materially modified at a time when the Fair Market
Value exceeds the SAR exercise price), is granted to an Employee with respect to whom Stock does not constitute “service recipient
stock” (as defined in Treasury Regulation Section 1.409A-1(b)(5)(iii)), or is otherwise determined to constitute “nonqualified
deferred compensation” within the meaning of Code Section 409A. Any such Stock Appreciation Right may provide that it is exercisable
at any time permitted under the governing written instrument, but such exercise shall be limited to fixing the measurement of the amount,
if any, by which the Fair Market Value of a share of Stock on the date of exercise exceeds the SAR exercise price (the “SAR Amount”).
However, once the Stock Appreciation Right is exercised, the SAR Amount may be paid only on the fixed time, payment schedule or other
event specified in the governing written instrument.

 

    	 	15	 

     

    

 

11.  OTHER
STOCK-BASED AWARDS. The Committee is authorized to grant Awards to Grantees in the form of Other
Stock-Based Awards, as deemed by the Committee to be consistent with the purposes of the Plan and as evidenced by an Award Agreement.
Other Stock-Based Awards shall include a right or other interest granted to a Grantee under the Plan that may be denominated or payable
in, valued in whole or in part by reference to, or otherwise based on or related to, Stock, including but not limited to dividend equivalents
or performance units, each of which may be subject to the attainment of Performance Goals or a period of continued employment or other
terms or conditions as determined by the Committee. The Committee shall determine the terms and conditions of such Other Stock-Based
Awards, consistent with the terms of the Plan, at the Date of Grant or thereafter, including any Performance Goals and Performance Periods.
Stock or other securities or property delivered pursuant to an Award in the nature of a purchase right granted under this Section 11
shall be purchased for such consideration, paid for at such times, by such methods, and in such forms, including, without limitation,
Stock, other Awards, notes or other property, as the Committee shall determine, subject to any required corporate action; provided, that
no Other Stock- Based Award shall vest less than 36 months after it is granted, except in the event of a Change in Control as provided
in Section 12(e) or as provided in Section 5(d).

 

		12.	ADJUSTMENT
                                            OF AND CHANGES IN CAPITALIZATION; CHANGE IN CONTROL.

 

(a)     In
the event that the outstanding shares of Stock shall be changed in number or class or the capital structure of the Company shall be changed
by reason of stock splits, reverse stock splits, split-ups, spin-offs, combinations, mergers, consolidations, recapitalizations, or by
reason of Stock dividends or other relevant changes in capitalization, the number or class of shares of Stock which thereafter may be
issued pursuant to Awards granted under the Plan, both in the aggregate and as to any individual, the number and class of shares of Stock
then subject to Awards theretofore granted, the exercise price of Options and Stock Appreciation Rights and the Performance Goals to
which Awards are subject shall be equitably adjusted or substituted, as to the number, price or kind of a share of Stock or other consideration
subject to such Awards so as to reflect such change to the extent necessary to preserve the economic intent of such Awards, all as determined
by the Committee. In the event there shall be any other change in the number or kind of the outstanding shares of Stock, or of any stock
or other securities or property into which such shares of Stock shall have been changed, or for which it shall have been exchanged, then
if the Committee shall determine that such change equitably requires an adjustment in any outstanding Award theretofore granted or which
may be granted under the Plan, such adjustment shall be made in accordance with such determination. Any adjustments under this Section 12
shall be made in a manner which does not adversely affect the exemption provided pursuant to Rule 16b-3 or, unless the Committee
determines that such adjustment is in the best interests of the Company and its Affiliates, otherwise result in a violation of Code Section 409A
or the disqualification of any Incentive Stock Option.

 

(b)     Notice
of any adjustment shall be given by the Company to each Grantee with an Award which shall have been so adjusted and such adjustment (whether
or not such notice is given) shall be effective and binding for all purposes of the Plan.

 

(c)     Fractional
shares of Stock resulting from any adjustment of Awards pursuant to this Section 12 may be settled in cash or otherwise as the Committee
may determine.

 

(d)     Notwithstanding
the above, in the event of any of the following: (i) the Company is merged or consolidated with another corporation or entity and,
in connection therewith, consideration is received by stockholders of the Company in a form other than stock or other equity interests
of the surviving entity or outstanding Awards are not to be assumed upon consummation of the proposed transaction; (ii) all or substantially
all of the assets of the Company are acquired by another person; (iii) the reorganization or liquidation of the Company; or (iv) the
Company shall enter into a written agreement to undergo an event described in clause (i), (ii) or (iii) above, then the Committee
may, in its discretion and upon at least 10 days’ advance notice to the affected persons, cancel any outstanding Awards and cause
the holders thereof to be paid, in cash, stock or other property, or any combination thereof, the value of such Awards based upon the
price per share of Stock received or to be received by other common stockholders of the Company in the event. The terms of this Section 12
may be varied by the Committee in any particular Award Agreement.

 

    	 	16	 

     

    

 

(e)     Double
Trigger Vesting. Subject to Section 12(g), in the event of a Change in Control, the vesting and forfeiture restrictions on outstanding
Awards shall not lapse as of the Change of Control; rather, for each outstanding Award, applicable time- and performance-based vesting
and forfeiture restrictions shall lapse, or the time of exercisability of such Award shall occur, on the earlier of (i) the original
date specified for the lapse of such vesting and forfeiture restrictions or for the time of exercise in the applicable Award Agreement,
or (ii) the date the Grantee’s employment or other service relationship with the Company and its subsidiaries is terminated
by the Company or a subsidiary without Cause or by the Grantee for Good Reason, provided such termination date (or, if applicable, the
action by the Company that constitutes “Good Reason”) occurs within 24 months following the date of such Change in Control.

 

(f)      Award
Adjustments. Subject to Section 12(g), in the event of a Change in Control, the Committee, in its discretion, may effect one or
more of the following actions that it deems appropriate in its sole discretion with respect to outstanding Awards, which
action(s) may vary among Awards granted to individual Grantees: (i) providing for the assumption, substitution or
continuation of Awards by the surviving entity or successor company or a parent or subsidiary thereof, with appropriate adjustments
to the number and kind of securities and any applicable terms to provide substantially equivalent value, vesting requirements and
other terms and attributes of the affected Awards; provided, however, that in the event the surviving entity or successor company or
a parent or subsidiary thereof does not assume, substitute or continue Awards, or the Committee determines, in its sole discretion,
that substantially equivalent value, vesting requirements and other terms and attributes will not be provided by any such assumed,
substituted or continued awards, the Committee may (x) accelerate the vesting or exercisability terms of the affected Awards to
the date of such Change in Control, notwithstanding Section 12(e), or (y) provide for a payment (in cash or, in the sole
discretion of the Committee, in the form of such other consideration necessary for a Grantee to receive property, cash, or
securities (or combination thereof) as such Grantee would have been entitled to receive upon the occurrence of the Change in Control
if the Grantee had been, immediately prior to such Change in Control, the holder of the number of shares of Stock covered by the
Award at such time (less any applicable exercise price)) with respect to outstanding Awards equal to the value of such Awards, as
determined by the Committee, by requiring the mandatory surrender to the Company by selected Grantees of some or all of the
outstanding Awards held by such Grantees (irrespective of whether such Awards are then vested or exercisable pursuant to the Plan)
as of a date, before or after such Change in Control, specified by the Committee; or (ii) making such adjustments to Awards
then outstanding as the Committee deems appropriate to reflect such Change in Control; provided, however, that the Committee may
determine in its sole discretion that no adjustment is necessary to Awards then outstanding; provided further, however, that no
action may be taken that would reduce the value of an Award. Notwithstanding the discretion given to the Committee above, if any
Award is subject to Code Section 409A and any action described above would be deemed a non-compliant modification of such Award
under Code Section 409A, then such action shall not be taken with respect to such Award and such Award may instead be treated
in such other manner determined by the Committee that is compliant with Code Section 409A.

 

(g)     Notwithstanding
any contrary provision contained herein, for any Award outstanding as of any date prior to the Effective Date Section 12(e) and
Section 12(f) shall not apply, and the terms of such Award Agreement shall govern the effect on such Award of a Change in Control.

 

(h)     The
obligations of the Company under the Plan shall be binding upon any successor corporation or organization resulting from the merger,
consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to all or substantially
all of the assets and business of the Company and its Affiliates, taken as a whole.

 

		13.	SECURITIES
                                            ACT REQUIREMENTS.

 

(a)     No
shares of Stock shall be purchased or sold under an Award if such purchase or sale, or issuance of Stock would, in the opinion of
counsel for the Company, violate the Securities Act or other Federal or state statutes or regulatory agency rules having
similar requirements, as they may be in effect at that time; and each Award shall be subject to the further requirement that, at any
time that the Committee shall determine, in their respective discretion, that the listing, registration or qualification of the
Stock subject to such Award under any securities exchange requirements or under any Applicable Law, or the consent or approval of
any governmental regulatory body, is necessary or desirable as a condition of, or in connection with, the granting of such Award or
the issuance of Stock thereunder, such Award may not be exercised or issued, as the case may be, in whole or in part unless such
listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable
to the Committee.

 

    	 	17	 

     

    

 

(b)     As
a condition to the issuance of any Award that may be settled in Stock under the Plan, the Committee may require the Grantee to
furnish a written representation that he or she is acquiring such Award for investment and not with a view to distribution of the
Stock to the public and a written agreement restricting the transferability of the Stock of such Award, and may affix a restrictive
legend or legends on the face of the certificate representing such Stock. Such representation, agreement and/or legend shall be
required only in cases where in the opinion of the Committee and counsel for the Company, it is necessary to enable the Company to
comply with the provisions of the Securities Act or other Federal or state statutes having similar requirements, and any stockholder
who gives such representation and agreement shall be released from it and the legend removed at such time as the shares of Stock to
which they applied are registered or qualified pursuant to the Securities Act or other Federal or state statutes having similar
requirements, or at such other time as, in the opinion of the Committee and counsel for the Company, the representation and
agreement and legend cease to be necessary to enable the Company to comply with the provisions of the Securities Act or other
Federal or state statutes having similar requirements.

 

		14.	PERFORMANCE
                                            COMPENSATION AWARDS.

 

(a)     The
Committee shall have the authority, at the time of grant of any Award described in this Plan (other than Options and Stock Appreciation
Rights granted with an exercise price equal to or greater than the Fair Market Value per share of Stock on the Date of Grant), to designate
such Award or a portion of such Award as a “Performance Compensation Award.”

 

(b)     The
Committee will, in its sole discretion, designate which Grantees will be eligible to receive Performance Compensation Awards in
respect of a Performance Period. However, designation of a Grantee eligible to receive an Award hereunder for a Performance Period
shall not in any manner entitle the Grantee to receive payment in respect of any Performance Compensation Award for such Performance
Period. The determination as to whether or not such Grantee becomes entitled to payment in respect of any Performance Compensation
Award shall be decided solely in accordance with the provisions of this Section 14. Moreover, designation of a Grantee eligible
to receive an Award hereunder for a particular Performance Period shall not require designation of such Grantee eligible to receive
an Award hereunder in any subsequent Performance Period and designation of one person as a Grantee eligible to receive an Award
hereunder shall not require designation of any other person as a Grantee eligible to receive an Award hereunder in such period or in
any other period.

 

(c)     Subject
to any minimum period under the Plan for an Award to be exercisable or vest, as modified by Section 5(d), with regard to a particular
Performance Period, the Committee shall have full discretion to select the length of such Performance Period, the type(s) of Performance
Compensation Awards to be issued, the Performance Criteria that will be used to establish the Performance Goal(s), the kind(s) and/or
level(s) of the Performance Goals(s) that is (are) to apply and the Performance Formula, if any.

 

(d)     Payment
of Performance Compensation Awards.

 

(i)       Unless
otherwise provided in the applicable Award Agreement, a Grantee must be employed by the Company or an Affiliate on the last day of a
Performance Period to be eligible for payment in respect of a Performance Compensation Award for such Performance Period.

 

(ii)      A
Grantee shall be eligible to receive payment in respect of a Performance Compensation Award only to the extent that: (A) the applicable
Performance Goals for the Performance Period are achieved, as determined by the Committee; and (B) all or some portion of such Grantee’s
Performance Compensation Award has been earned for the Performance Period based on the application of any Performance Formula to such
Performance Goals, as determined by the Committee. Subject to any minimum period under the Plan for an Award to be exercisable or vest,
as modified by Section 5(d), the Committee may accelerate the vesting and/or the lapse of any or all of the restrictions on a Performance
Compensation Award, which acceleration shall not affect any other terms and conditions of such Award.

 

    	 	18	 

     

    

 

(iii)     Following
the completion of a Performance Period and prior to the payment of any Performance Compensation Award, the Committee shall review and
determine whether, and to what extent, the Performance Goals for the Performance Period have been achieved and, if so, calculate the
amount of the Performance Compensation Awards earned for the Performance Period, which may be based upon a Performance Formula. The Committee
shall then determine the actual size of each Grantee’s Performance Compensation Award for the Performance Period and, in so doing,
may apply discretion if and when it deems appropriate.

 

(iv)     Performance
Compensation Awards granted for a Performance Period shall be paid to Grantees as soon as administratively practicable following completion
of the determinations required by this Section 14.

 

(v)      Subject
to the adjustment provisions of Section 12, notwithstanding any provision contained in this Plan to the contrary, (A) no
more than 4,000,000 shares of Stock may be subject to Options granted under the Plan to any one individual during any five
(5) consecutive year period, (B) no more than 4,000,000 shares of Stock may be subject to Stock Appreciation Rights
granted under the Plan to any one individual during any five (5) consecutive year period, (C) no more than 3,000,000
shares of Restricted Stock may be granted under the Plan to any one individual during any five (5) consecutive year period,
(D) no more than 3,000,000 shares of Stock may be subject to Restricted Stock Units granted under the Plan to any one
individual during any five (5) consecutive year period, and (E) no more than 3,000,000 shares of Stock may be subject to
Other Stock-Based Awards granted under the Plan to any one individual during any five (5) consecutive year period.

 

(vi)     With
respect to Restricted Stock and Restricted Stock Units that are designated as Performance Compensation Awards, the Committee has the
discretion to determine whether dividends on such Restricted Stock and Dividend Equivalents on such Restricted Stock Units are intended
to constitute Performance Compensation Awards and whether such dividends or Dividend Equivalents must satisfy Performance Goals separately
from the underlying Restricted Stock or Restricted Stock Units.

 

(vii)    If,
after the attainment of the applicable Performance Goals, payment of a Performance Compensation Award in cash is accelerated to an
earlier date, the amount paid will be discounted to reasonably reflect the time value of money. Any Performance Compensation Award
that has been deferred shall not (between the date as of which the Award is deferred and the payment date) increase (A) with
respect to a Performance Compensation Award that is payable in cash, by a measuring factor for each fiscal year greater than a
reasonable rate of interest set by the Committee or (B) with respect to a Performance Compensation Award that is payable in
Stock, by an amount greater than the appreciation of a share of Stock from the date such Award is deferred to the payment
date.

 

15.  WITHHOLDING
OBLIGATIONS. To the extent provided by the terms of an Award Agreement and subject to the discretion
of the Committee, the Grantee may satisfy any federal, state, provincial or local tax withholding obligation relating to the exercise
or acquisition of Stock under an Award by any of the following means (in addition to the Company’s right to withhold from any compensation
paid to the Grantee by the Company) or by a combination of such means: (a) tendering a cash payment; (b) authorizing the Company
to withhold shares of Stock from the shares of Stock otherwise issuable to the Grantee as a result of the exercise or acquisition of
Stock under the Award, provided, however, that no shares of Stock are withheld with a value exceeding the maximum statutory tax rates
in the jurisdiction(s) applicable to the Grantee; or (c) delivering to the Company previously owned and unencumbered shares
of Stock.

 

		16.	AMENDMENT
                                            OF THE PLAN AND AWARDS.

 

(a)     The
Board may at any time and from time to time alter, amend, suspend, or terminate the Plan in whole or in part. However, the Board may
not make any alteration or amendment which would decrease any authority granted to the Committee hereunder in contravention of Rule 16b-3
and, except as provided in Section 12 relating to adjustments upon changes in Stock and Section 16(b), no amendment shall be
effective unless approved by the stockholders of the Company to the extent stockholder approval is necessary to satisfy any Applicable
Laws, rules, regulations or securities exchange listing requirements. At the time of such amendment, the Board shall determine, upon
advice from counsel, whether such amendment will be contingent on stockholder approval. The Board may, in its sole discretion, submit
any other amendment to the Plan for stockholder approval. No Awards may be granted under the Plan while the Plan is suspended or after
it is terminated, but Awards theretofore granted may extend beyond the date of Plan suspension or termination.

 

    	 	19	 

     

    

 

(b)     It
is expressly contemplated that the Board may amend the Plan in any respect the Board deems necessary or advisable to provide eligible
Employees and Consultants with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated
thereunder relating to Incentive Stock Options or to the nonqualified deferred compensation provisions of Code Section 409A and/or
to bring the Plan and/or Awards granted under it into compliance therewith.

 

(c)     Notwithstanding
the foregoing, no amendment to or termination of the Plan shall affect adversely any of the rights of any Grantee with respect to any
Award granted before such amendment of the Plan, without such Grantee’s consent in writing.

 

(d)     The
Committee at any time, and from time to time, may amend the terms of any one or more Awards; provided, however, that the Committee may
not effect any amendment which would otherwise constitute an impairment of the rights under any Award unless (a) the Company requests
the consent of the Grantee and (b) the Grantee consents in writing.

 

		17.	GENERAL
                                            PROVISIONS.

 

(a)     No
Employment or Other Service Rights. Nothing in the Plan or any instrument executed or Award granted pursuant thereto shall confer upon
any Grantee any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or
shall affect the right of the Company or an Affiliate to terminate (i) the employment of an Employee with or without notice and
with or without cause, or (ii) the service of a Consultant pursuant to the terms of such Consultant’s agreement with the Company
or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated,
as the case may be.

 

(b)     Code
Section 409A. The Plan and each Award granted hereunder is intended to comply with Code Section 409A to the extent subject
thereto, and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to be in compliance
therewith. Any payments described in the Plan or an Award that are due within the “short-term deferral period,” as
described in Code Section 409A and the regulations and other guidance issued thereunder, shall not be treated as nonqualified
deferred compensation unless Applicable Laws require otherwise. If the Board (or its delegate) determines in its discretion that an
Award is determined to be “nonqualified deferred compensation” subject to Code Section 409A, and that the Grantee
is a “specified employee” as defined in Code Section 409A(a)(2)(B)(i) and the regulations and other guidance
issued thereunder, then any amounts that would otherwise by payable and benefits that would otherwise be provided pursuant to the
Plan during the six (6) month period immediately following the Grantee’s separation from service shall instead be paid on
the first payroll date after the six-month anniversary of the Grantee’s separation from service (or the Grantee’s death,
if earlier). For purposes of Code Section 409A, each payment in a series of installments shall be considered a separate
payment. Notwithstanding any other provision contained herein, terms such as “termination of service,”
 “termination of employment” and “termination of engagement” shall mean a “separation from
service” within the meaning of Code Section 409A, to the extent any exercise or distribution hereunder could be deemed
 “nonqualified deferred compensation” for purposes thereof. Notwithstanding the foregoing, neither the Company nor the
Committee shall have any obligation to take any action to prevent the assessment of any excise tax or penalty on any Grantee under
Code Section 409A, and neither the Company nor the Committee will have any liability to any Grantee for such tax or
penalty.

 

(c)     Share
Certificates and Book Entry. To the extent that the Plan provides for issuance of stock certificates to represent shares of Stock, the
issuance may be effected on a non-certificated basis to the extent permitted by applicable law and the applicable rules of any national
securities exchange or system on which the Stock is then listed or reported. Notwithstanding any provision of the Plan to the contrary,
in its discretion the Committee may satisfy any obligation to deliver shares represented by stock certificates by delivering shares in
book-entry or electronic form. If the Company issues any shares in book-entry or electronic form that are subject to terms, conditions
and restrictions on transfer, a notation shall be made in the records of the transfer agent with respect to any such shares describing
all applicable terms, conditions and restrictions on transfer. In the case of Restricted Stock granted under the Plan, such notation
shall reflect the legend described in Section 8(i).

 

    	 	20	 

     

    

 

(d)     Section 16.
It is the intent of the Company that the Plan satisfy, and be interpreted in a manner that satisfies, the applicable requirements of
Rule 16b-3 so that Grantees will be entitled to the benefit of Rule 16b-3, or any other rule promulgated under Section 16
of the Exchange Act, and will not be subject to short-swing liability under Section 16 of the Exchange Act. Accordingly, if the
operation of any provision of the Plan would conflict with the intent expressed in this Section 17(d), such provision to the extent
possible shall be interpreted and/or deemed amended so as to avoid such conflict.

 

(e)     Unfunded
Plan. The Plan shall be unfunded. Neither the Company, the Board nor the Committee shall be required to establish any special or separate
fund or to segregate any assets to assure the performance of its obligations under the Plan.

 

(f)      Severability.
If any of the provisions of the Plan or any Award Agreement is held to be invalid, illegal or unenforceable, whether in whole or in part,
such provision shall be deemed modified to the extent, but only to the extent, of such invalidity, illegality or unenforceability and
the remaining provisions shall not be affected thereby.

 

(g)     Forfeiture
Events. The Committee may specify in an Award Agreement that the Grantee’s rights, payments and benefits with respect to an Award
shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain events, in addition to applicable
vesting conditions of an Award. Such events may include, without limitation, breach of non-competition, non-solicitation, confidentiality,
or other restrictive covenants that are contained in the Award Agreement or otherwise applicable to the Grantee, a termination of the
Grantee’s employment or other service for cause, or other conduct by the Grantee that is detrimental to the business or reputation
of the Company and/or its Affiliates.

 

(h)     Beneficiary
Designation. Each Grantee under the Plan may from time to time name any beneficiary or beneficiaries by whom any right under the Plan
is to be exercised in case of such Grantee’s death. Each designation will revoke all prior designations by the same Grantee, shall
be in a form reasonably prescribed by the Committee and shall be effective only when filed by the Grantee in writing with the Company
during the Grantee’s lifetime.

 

(i)      Non-Uniform
Treatment. The Committee’s determinations under the Plan need not be uniform and may be made by it selectively among persons who
are eligible to receive, or actually receive, Awards. Without limiting the generality of the foregoing, the Committee shall be entitled
to make non-uniform and selective determinations, amendments and adjustments, and to enter into non-uniform and selective Award Agreements.

 

(j)      No
Guarantee of Tax Consequences. None of the Company, its Affiliates, the Board, the Committee or any officer, employee, agent or
representative of any of the foregoing makes any commitment or guarantee with respect to the Plan or any Award granted hereunder
that any particular tax treatment will (or will not) apply with respect to any Grantee (or any party claiming through or on behalf
of any Grantee), including any tax consequences under Code Section 409A, or assumes and liability or responsibility with
respect thereto.

 

18.  CHANGES
IN LAW. The Board may amend the Plan and any outstanding Awards granted thereunder in such respects
as the Board shall, in its sole discretion, deem advisable in order to incorporate in the Plan or any such Awards any new provision or
change designed to comply with or take advantage of requirements or provisions of the Code or any other statute, or rules or regulations
of the Internal Revenue Service or any other federal or state governmental agency enacted or promulgated after the adoption of the Plan.

 

19.  CLAWBACKS.
To the extent required by Company policy or Applicable Laws, rules, regulations or securities exchange listing requirements, the Company
shall have the right, and shall take all actions necessary, to recover any amounts paid to any individual under this Plan.

 

    	 	21	 

     

    

 

		20.	LEGAL
                                            MATTERS.

 

(a)     Every
right of action by or on behalf of the Company or by any stockholder against any past, present or future member of the Board,
officer or employee of the Company arising out of or in connection with this Plan shall, irrespective of the place where such action
may be brought and irrespective of the place of residence of any such Grantee, cease and be barred by the expiration of three years
from whichever is the later of (i) the date of the act or omission in respect of which such right of action arises, or
(ii) the first date upon which there has been made generally available to stockholders an annual report of the Company and a
proxy statement for the annual meeting of stockholders following the issuance of such annual report, which annual report and proxy
statement alone or together set forth, for the related period, the aggregate number of shares of Stock for which Awards were
granted; and any and all rights of action by any employee or executive of the Company (past, present or future) against the Company
arising out of or in connection with this Plan shall, irrespective of the place where such action may be brought, cease and be
barred by the expiration of three years from the date of the act or omission in respect of which such right of action
arises.

 

(b)     This
Plan and all determinations made and actions taken pursuant hereto shall be governed by the law of Texas, applied without giving effect
to any conflicts-of-law principles, and construed accordingly.

 

21.  ELECTRONIC
DELIVERY AND ACCEPTANCE. The Company may, in its sole discretion, deliver any documents related
to the Award by electronic means. To participate in the Plan, a Grantee consents to receive all applicable documentation by electronic
delivery and through an on-line (and/or voice activated) system established and maintained by the Company or a third party vendor designated
by the Company.

 

22.  FOREIGN
EMPLOYEES. Without the amendment of this Plan, the Board may provide for the participation in
the Plan by employees who are subject to the laws of foreign countries or jurisdictions, and such participation may be on such terms
and conditions different from those specified in this Plan as may be administratively necessary or necessary or desirable to foster and
promote achievement of the purposes of this Plan and, in furtherance of such purposes the Board or its designee may make such modifications,
amendments, procedures, subprograms and the like as may be necessary or advisable to comply with the provisions of laws of other countries
or jurisdictions in which Affiliates operate or have employees.

 

    	 	22Exhibit 4.7

 

THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT
EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER
THAN (I) THINKEQUITY, A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC., OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE
OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF THINKEQUITY, A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC., OR OF ANY SUCH UNDERWRITER
OR SELECTED DEALER.

 

THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS 180 DAYS FROM THE EFFECTIVE DATE OF THE OFFERING].
VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].

 

WARRANT
TO PURCHASE COMMON STOCK 

 

IPSIDY
INC.

 

Warrant
Shares: _______

Initial
Exercise Date: ______, 20__

 

THIS
WARRANT TO PURCHASE COMMON STOCK (the “Warrant”) certifies that, for value received, _____________ or its assigns
(the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after ____, 20[●] (the “Initial Exercise Date”) and, in accordance with FINRA Rule
5110(g)(8)(A), prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the Effective Date (the “Termination
Date”) but not thereafter, to subscribe for and purchase from Ipsidy Inc., a Delaware corporation (the “Company”),
up to ______ shares of Common Stock, par value $0.0001 per share, of the Company (the “Warrant Shares”), as subject
to adjustment hereunder. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as
defined in Section 2(b).

 

Section
1. Definitions. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated
in this Section 1:

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

“Commission”
means the United States Securities and Exchange Commission.

 

     

     

    

 

“Effective
Date” means the effective date of the registration statement on Form S-1 (File No. [XXX-XXXXXX]), including any related prospectus
or prospectuses, for the registration of the Company’s Common Stock, par value $0.0001 per share and the Warrant Shares under the
Securities Act, that the Company has filed with the Commission.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Trading
Day” means a day on which the New York Stock Exchange is open for trading.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of a share of Common Stock for such date (or the nearest preceding date) on the OTCQB or OTCQX as applicable, (c) if Common
Stock is not then listed or quoted for trading on the OTCQB or OTCQX and if prices for Common Stock are then reported in the “Pink
Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of the Common
Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.

 

    2

     

    

 

Section
2. Exercise.

 

 iv) a) Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise Form annexed hereto. Within two (2) Trading Days following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within five (5) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise Form within two (2) Business Days of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

b) 
Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be $_______, subject to adjustment
hereunder (the “Exercise Price”).

 

c) 
Cashless Exercise. In lieu of exercising this Warrant by delivering the aggregate Exercise Price by wire transfer or cashier’s
check, at the election of the Holder this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless
exercise” in which the Holder shall be entitled to receive the number of Warrant Shares equal to the quotient obtained by dividing
[(A-B) (X)] by (A), where:

 

		(A)	=	 as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of “regular trading hours” (as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal
securities laws) on such Trading Day, (ii) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours
thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section
2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day
and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading
hours” on such Trading Day;

 

    3

     

    

 

		(B)	= 	the Exercise Price of this Warrant, as adjusted hereunder;
and

 

		(X)	= 	the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.

 

If
Warrant Shares are issued in such a “cashless exercise,” the parties acknowledge and agree that in accordance with Section
3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the
holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares.  The Company agrees
not to take any position contrary to this Section 2(c). 

 

Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).

 

d) 
Mechanics of Exercises.

 

 iv. i.  Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by its transfer agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder, or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 and, in either case, the Warrant Shares have been sold by the Holder prior to the Warrant Share Delivery Date (as defined below), and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is two (2) Trading Days after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). If the Warrant Shares can be delivered via DWAC, the transfer agent shall have received from the Company, at the expense of the Company, any legal opinions or other documentation required by it to deliver such Warrant Shares without legend (subject to receipt by the Company of reasonable back up documentation from the Holder, including with respect to affiliate status) and, if applicable and requested by the Company prior to the Warrant Share Delivery Date, the transfer agent shall have received from the Holder a confirmation of sale of the Warrant Shares (provided the requirement of the Holder to provide a confirmation as to the sale of Warrant Shares shall not be applicable to the issuance of unlegended Warrant Shares upon a cashless exercise of this Warrant if the Warrant Shares are then eligible for resale pursuant to Rule 144(b)(1)). The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(vi) prior to the issuance of such shares, having been paid. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the second Trading Day following the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after the second Trading Day following such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.

 

    4

     

    

  

 ii. Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

 iii. Rescission Rights. If the Company fails to cause its transfer agent to deliver to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; provided, however, that the Holder shall be required to return any Warrant Shares or Common Stock subject to any such rescinded exercise notice concurrently with the return to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration of Holder’s right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).

 

 iv. Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

    5

     

    

  

 v. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

 vi. Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all transfer agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

 vii. Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

viii.
Signature. This Section 2 and the exercise form attached hereto set forth the totality of the procedures required of the Holder
in order to exercise this Purchase Warrant.  Without limiting the preceding sentences, no ink-original exercise form shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any exercise form be required in order to exercise
this Purchase Warrant.  No additional legal opinion, other information or instructions shall be required of the Holder to exercise
this Purchase Warrant.  The Company shall honor exercises of this Purchase Warrant and shall deliver Shares underlying this Purchase
Warrant in accordance with the terms, conditions and time periods set forth herein.

 

    6

     

    

 

e) 
Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess of the
Beneficial Ownership Limitation (as defined below).  For purposes of the foregoing sentence, the number of shares of Common Stock
beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this
Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be
issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates
and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without
limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained
herein beneficially owned by the Holder or any of its Affiliates.  Except as set forth in the preceding sentence, for purposes of
this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation
is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in
accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates)
and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall
have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of
outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission,
as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Company’s
transfer agent setting forth the number of shares of Common Stock outstanding.  Upon the written or oral request of a Holder, the
Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. 
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding
shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 9.99% of the number of shares
of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this
Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section
2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions
of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st
day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner
otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be
defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary
or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder
of this Warrant. 

 

    7

     

    

   

Section
3. Certain Adjustments.

 

a) 
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification. For the purposes of clarification, the Exercise Price
of this Warrant will not be adjusted in the event that the Company or any Subsidiary thereof, as applicable, sells or grants any option
to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option
to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise
Price then in effect.

 

b) 
[RESERVED]

  

c) 
Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the
Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

    8

     

    

 

d) 
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other
than cash dividends) or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way
of return of capital or otherwise (including, without limitation, any distribution of shares or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a "Distribution"),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the
Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the
beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.

  

e) 
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock,
(iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each
a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the “Alternate Consideration”) receivable by holders of Common Stock as a result of such Fundamental
Transaction for each share of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and
power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor
Entity had been named as the Company herein.

 

    9

     

    

   

f)  
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

g) 
Notice to Holder.

 

i.  Adjustment to Exercise Price. Whenever the Exercise Price
is adjusted pursuant to any provision of this Section 3, the Company shall promptly mail to the Holder a notice setting forth the Exercise
Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts
requiring such adjustment.

 

ii.  Notice to
Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of
the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property,
or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company,
then, in each case, the Company shall cause to be mailed a notice to the Holder at its last address as it shall appear upon the Warrant
Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, stating (x)
the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record
is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to provide such notice or any defect therein shall
not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder
constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.

  

    10

     

    

 

Section
4. Transfer of Warrant.

 

a) 
Transferability. Pursuant to FINRA Rule 5110(e)(1)(A), neither this Warrant nor any Warrant Shares issued upon exercise of this
Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put,
or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days
immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued,
except the transfer of any security:

 

i. 
by operation of law or by reason of reorganization of the Company;

 

ii.
to any FINRA member firm participating in the offering and the officers or partners thereof, if all securities so transferred remain
subject to the lock-up restriction in this Section 4(a) for the remainder of the time period;

 

iii.
if the aggregate amount of securities of the Company held by the Holder or related person do not exceed 1% of the securities being offered;

 

iv.
that is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member manages
or otherwise directs investments by the fund, and participating members in the aggregate do not own more than 10% of the equity in the
fund; or

 

v. 
the exercise or conversion of any security, if all securities received remain subject to the lock-up restriction in this Section 4(a)
for the remainder of the time period.

  

Subject
to the foregoing restriction, any applicable securities laws and the conditions set forth in Section 4(d), this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning this Warrant
full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.

 

b) 
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c) 
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
“Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.

 

d) 
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.

  

    11

     

    

 

Section
5. Registration Rights.

 

5.1 
Demand Registration.

 

5.1.1 Grant
of Right. The Company, upon written demand (a “Demand Notice”) of the Holder(s) of at least 51% of the Warrants and/or the
underlying Warrant Shares (“Majority Holders”), agrees to register, on one occasion, all or any portion of the Warrant Shares
underlying the Warrants (collectively, the “Registrable Securities”). On such occasion, the Company will file a registration
statement with the Commission covering the Registrable Securities within sixty (60) days after receipt of a Demand Notice and use its
reasonable best efforts to have the registration statement declared effective promptly thereafter, subject to compliance with review
by the Commission; provided, however, that the Company shall not be required to comply with a Demand Notice if the Company has filed
a registration statement with respect to which the Holder is entitled to piggyback registration rights pursuant to Section 5.2 hereof
and either: (i) the Holder has elected to participate in the offering covered by such registration statement or (ii) if such registration
statement relates to an underwritten primary offering of securities of the Company, until the offering covered by such registration statement
has been withdrawn or until thirty (30) days after such offering is consummated. The demand for registration may be made at any time
beginning on the Initial Exercise Date and expiring on the fifth anniversary of the Effective Date. The Company covenants and agrees
to give written notice of its receipt of any Demand Notice by any Holder(s) to all other registered Holders of the Warrants and/or the
Registrable Securities within ten (10) days after the date of the receipt of any such Demand Notice.

 

5.1.2
 Terms. The Company shall bear all fees and expenses attendant to the registration
of the Registrable Securities pursuant to Section 5.1.1, but the Holders shall pay any and all underwriting commissions and the expenses
of any legal counsel selected by the Holders to represent them in connection with the sale of the Registrable Securities. The Company
agrees to use its reasonable best efforts to cause the filing required herein to become effective promptly and to qualify or register
the Registrable Securities in such States as are reasonably requested by the Holder(s); provided, however, that in no event shall the
Company be required to register the Registrable Securities in a State in which such registration would cause: (i) the Company to be obligated
to register or license to do business in such State or submit to general service of process in such State, or (ii) the principal shareholders
of the Company to be obligated to escrow their shares of capital stock of the Company. The Company shall cause any registration statement
filed pursuant to the demand right granted under Section 5.1.1 to remain effective for a period of at least twelve (12) consecutive months
after the date that the Holders of the Registrable Securities covered by such registration statement are first given the opportunity
to sell all of such securities. The Holders shall only use the prospectuses provided by the Company to sell the Warrant Shares covered
by such registration statement, and will immediately cease to use any prospectus furnished by the Company if the Company advises the
Holder that such prospectus may no longer be used due to a material misstatement or omission. Notwithstanding the provisions of this
Section 5.1.2, the Holder shall be entitled to a demand registration under this Section 5.1.2 on only one (1) occasion and such demand
registration right shall terminate on the fifth anniversary of the date of the Underwriting Agreement (as defined below) in accordance
with FINRA Rule 5110(g)(8)(B) and (C).

 

    12

     

    

 

5.2
“Piggy-Back” Registration.

 

5.2.1 Grant
of Right. In addition to the demand right of registration described in Section 5.1 hereof, the Holder shall have the right, for a period
of no more than two (2) years from the Initial Exercise Date in accordance with FINRA Rule 5110(g)(8)(D), to include the Registrable
Securities as part of any other registration of securities filed by the Company (other than in connection with a transaction contemplated
by Rule 145(a) promulgated under the Securities Act or pursuant to Form S-8 or any equivalent form); provided, however, that if, solely
in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s) thereof shall,
in its reasonable discretion, impose a limitation on the number of Shares which may be included in the Registration Statement because,
in such underwriter(s)’ judgment, marketing or other factors dictate such limitation is necessary to facilitate public distribution,
then the Company shall be obligated to include in such Registration Statement only such limited portion of the Registrable Securities
with respect to which the Holder requested inclusion hereunder as the underwriter shall reasonably permit. Any exclusion of Registrable
Securities shall be made pro rata among the Holders seeking to include Registrable Securities in proportion to the number of Registrable
Securities sought to be included by such Holders; provided, however, that the Company shall not exclude any Registrable Securities unless
the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such
Registration Statement or are not entitled to pro rata inclusion with the Registrable Securities.

 

5.2.2
 Terms. The Company shall bear all fees and expenses attendant to registering
the Registrable Securities pursuant to Section 5.2.1 hereof, but the Holders shall pay any and all underwriting commissions and the expenses
of any legal counsel selected by the Holders to represent them in connection with the sale of the Registrable Securities. In the event
of such a proposed registration, the Company shall furnish the then Holders of outstanding Registrable Securities with not less than
thirty (30) days written notice prior to the proposed date of filing of such registration statement. Such notice to the Holders shall
continue to be given for each registration statement filed by the Company during the two (2) year period following the Initial Exercise
Date until such time as all of the Registrable Securities have been sold by the Holder. The holders of the Registrable Securities shall
exercise the “piggy-back” rights provided for herein by giving written notice within ten (10) days of the receipt of the
Company’s notice of its intention to file a registration statement. Except as otherwise provided in this Warrant, there shall be
no limit on the number of times the Holder may request registration under this Section 5.2.2; provided, however, that such registration
rights shall terminate on the second anniversary of the Initial Exercise Date.

 

5.3
General Terms

 

5.3.1 Indemnification.
The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder and
each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section 20 (a) of the Exchange
Act against all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably
incurred in investigating, preparing or defending against any claim whatsoever) to which any of them may become subject under the Securities
Act, the Exchange Act or otherwise, arising from such registration statement but only to the same extent and with the same effect as
the provisions pursuant to which the Company has agreed to indemnify the Underwriters contained in Section 5.1 of the Underwriting Agreement
between the Underwriters and the Company, dated as of [___], 2021. The Holder(s) of the Registrable Securities to be sold pursuant to
such registration statement, and their successors and assigns, shall severally, and not jointly, indemnify the Company, against all loss,
claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating,
preparing or defending against any claim whatsoever) to which they may become subject under the Securities Act, the Exchange Act or otherwise,
arising from information furnished by or on behalf of such Holders, or their successors or assigns, in writing, for specific inclusion
in such registration statement to the same extent and with the same effect as the provisions contained in Section 5.2 of the Underwriting
Agreement pursuant to which the Underwriters have agreed to indemnify the Company.

 

    13

     

    

 

5.3.2
 Exercise of Warrants. Nothing contained in this Warrant shall be construed
as requiring the Holder(s) to exercise their Warrants prior to or after the initial filing of any registration statement or the effectiveness
thereof.

 

5.3.3
 Documents Delivered to Holders. The Company shall furnish to each Holder
participating in any of the foregoing offerings and to each underwriter of any such offering, if any, a signed counterpart, addressed
to such Holder or underwriter, of: (i) an opinion of counsel to the Company, dated the effective date of such registration statement
(and, if such registration includes an underwritten public offering, an opinion dated the date of the closing under any underwriting
agreement related thereto), and (ii) a “cold comfort” letter dated the effective date of such registration statement (and,
if such registration includes an underwritten public offering, a letter dated the date of the closing under the underwriting agreement)
signed by the independent registered public accounting firm which has issued a report on the Company’s financial statements included
in such registration statement, in each case covering substantially the same matters with respect to such registration statement (and
the prospectus included therein) and, in the case of such accountants’ letter, with respect to events subsequent to the date of
such financial statements, as are customarily covered in opinions of issuer’s counsel and in accountants’ letters delivered
to underwriters in underwritten public offerings of securities. The Company shall also deliver promptly to each Holder participating
in the offering requesting the correspondence and memoranda described below and to the managing underwriter, if any, copies of all correspondence
between the Commission and the Company, its counsel or auditors and all memoranda relating to discussions with the Commission or its
staff with respect to the registration statement and permit each Holder and underwriter to do such investigation, upon reasonable advance
notice, with respect to information contained in or omitted from the registration statement as it deems reasonably necessary to comply
with applicable securities laws or rules of FINRA. Such investigation shall include access to books, records and properties and opportunities
to discuss the business of the Company with its officers and independent auditors, all to such reasonable extent and at such reasonable
times as any such Holder shall reasonably request.

 

5.3.4
 Underwriting Agreement. The Company shall enter into an underwriting agreement
with the managing underwriter(s), if any, selected by any Holders whose Registrable Securities are being registered pursuant to this
Section 5, which managing underwriter shall be reasonably satisfactory to the Company. Such agreement shall be reasonably satisfactory
in form and substance to the Company, each Holder and such managing underwriters, and shall contain such representations, warranties
and covenants by the Company and such other terms as are customarily contained in agreements of that type used by the managing underwriter.
The Holders shall be parties to any underwriting agreement relating to an underwritten sale of their Registrable Securities and may,
at their option, require that any or all the representations, warranties and covenants of the Company to or for the benefit of such underwriters
shall also be made to and for the benefit of such Holders. Such Holders shall not be required to make any representations or warranties
to or agreements with the Company or the underwriters except as they may relate to such Holders, their Warrant Shares and their intended
methods of distribution.

 

5.3.5
 Documents to be Delivered by Holder(s). Each of the Holder(s) participating
in any of the foregoing offerings shall furnish to the Company a completed and executed questionnaire provided by the Company requesting
information customarily sought of selling security holders.

 

    14

     

    

 

5.3.6
 Damages. Should the registration or the effectiveness thereof required by
Sections 5.1 and 5.2 hereof be delayed by the Company or the Company otherwise fails to comply with such provisions, the Holder(s) shall,
in addition to any other legal or other relief available to the Holder(s), be entitled to obtain specific performance or other equitable
(including injunctive) relief against the threatened breach of such provisions or the continuation of any such breach, without the necessity
of proving actual damages and without the necessity of posting bond or other security.

 

Section
6. Miscellaneous.

 

a) 
No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i).

 

b) 
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any certificate relating to the Warrant Shares, and
in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall
not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company
will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or
stock certificate.

 

c) 
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.

 

d) 
Authorized Shares.

 

The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).

  

Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

    15

     

    

  

Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.

 

e) 
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the underwriting agreement, dated June [●], 2021, by and between the Company and ThinkEquity,
a division of Fordham Financial Management, Inc., as representatives of the underwriters set forth therein (the “Underwriting Agreement”).

 

f)  
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

g) 
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Underwriting Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h) 
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Underwriting Agreement.

  

i)   
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.

 

j)   
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.

 

    16

     

    

 

k) 
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.

 

l)  
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.

 

m)  
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.

 

n) 
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.

 

********************

 

(Signature
Page Follows)

 

    17

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.

 

	 	IPSIDY INC.
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

     

     

    

 

NOTICE
OF EXERCISE

 

		TO:	ipsidy
inc.

 

               _________________

 

(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2)
Payment shall take the form of (check applicable box):

 

		☐	in
lawful money of the United States; or

 

		☐	if
permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c),
to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).

 

(3)  
Please register and issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

The
Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:

 

_______________________________

 

_______________________________

 

_______________________________

 

(4)  
Accredited Investor. If the Warrant is being exercised via cash exercise, the undersigned is an “accredited investor”
as defined in Regulation D promulgated under the Securities Act of 1933, as amended

 

[SIGNATURE
OF HOLDER]

 

Name
of Investing Entity: _______________________________________________________________

 

Signature
of Authorized Signatory of Investing Entity: _________________________________________

 

Name
of Authorized Signatory: ___________________________________________________________

 

Title
of Authorized Signatory: ____________________________________________________________

 

Date:
________________________________________________________________________________

 

     

     

    

 

ASSIGNMENT
FORM

 

(To
assign the foregoing warrant, execute

this form and supply required information.

Do not use this form to exercise the warrant.)

  

FOR
VALUE RECEIVED, [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

 

_______________________________________________
whose address is

 

_______________________________________________________________.

 

 

_______________________________________________________________

 

Dated:
______________, _______

 

Holder’s
Signature: _____________________________

 

Holder’s
Address: _____________________________

 

_____________________________

  

NOTE:
The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement
or any change whatsoever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper
evidence of authority to assign the foregoing Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]